Views & Analysis | Perspectives on pharma industry issues

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Articles

Innovation and crowdsourcing in clinical trials: Interview w...

Angela Dunn interviews Dr Tomasz Sablinski of Transparency Life Sciences, the world’s first drug development company based on Open Innovation (OI). According to the "2012 State of Global Open Innovation", Forrester defines Open Innovation (OI) as...

Articles

Top ten innovators in pharma: Rob Müller

Rob Müller is our latest pharma innovator, nominated by his peers for his trailblazing efforts in social media. We asked you to nominate those who you considered to be a top innovator in pharma. We were delighted with your responses...

Articles

Tunnah’s musings: Pharma, lend me your ears and we’ll give y...

As he steps back into the ‘musings’ saddle, Paul Tunnah is back from vacation refreshed and ready to go, with some exciting news about a new feature on pharmaphorum. You probably noticed that, last month, this regular ‘musings’ column was written by Rebecca Aris rather than me. That’s because I took a short holiday…

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.

Digital